Xylo Technologies Ltd Depositary Receipt (XYLO)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Xylo Technologies Ltd Depositary Receipt (XYLO) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Xylo Technologies Ltd Depositary Receipt ever had a stock split?
Xylo Technologies Ltd Depositary Receipt Profile
| Technology Hardware, Storage & Peripherals Industry | Information Technology Sector | Liron Carmel CEO | NASDAQ (CM) Exchange | 58471G409 CUSIP |
| IL Country | 38 Employees | 28 Dec 2022 Last Dividend | 14 Nov 2022 Last Split | 5 Aug 2015 IPO Date |
Overview
Medigus Ltd. is a technology-centered company that specializes in developing medical devices and products, offering innovative solutions across a broad range of applications. Founded in 1999 and based in Tel Aviv-Yafo, Israel, Medigus serves a global market, including the United States, Europe, Asia, and Israel. Its diverse operations span across several segments: Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others. This broad spectrum of activities underlines the company's commitment to leveraging technology in various domains, from medical devices to digital platforms and consumer products.
Products and Services
- Medigus Ultrasonic Surgical Endostapler
- Biological Gels
- Digital Advertising Platform
- Online Consumer Products Sales
- Online Event Management and Ticketing Platform
- Miniaturized Imaging Equipment
- Electric Vehicles
- Wireless Vehicle Battery Charging Technologies
An innovative endoscopy system intended for the treatment of gastroesophageal reflux disease (GERD). This product showcases Medigus's commitment to advancing medical procedures through technology, providing a less invasive option for patients suffering from GERD.
Development of biological gels aimed at protecting individuals from biological threats. These gels are designed to minimize the entry of allergens and viruses through the upper airways and eye cavities, reflecting the company's efforts in public health and safety.
A platform that facilitates digital advertising, which demonstrates Medigus's diversification into online marketing solutions. This service leverages advanced technology to optimize online advertising and Internet traffic routing, helping businesses achieve better visibility and engagement with their target audience.
Operation of online stores for the sale of a variety of consumer products through the Amazon online marketplace. This aspect of Medigus's operations represents its venture into the e-commerce space, enabling direct sales and distribution of products to consumers internationally.
The company also offers an online platform for event management and ticketing, catering to the comprehensive needs of event organizers. This service simplifies the planning, promotion, and execution of events, illustrating Medigus's capacity for digital innovation beyond its medical device core.
Medigus develops, produces, and markets advanced miniaturized imaging equipment and visualization solutions. This product line is crucial for medical diagnostics and procedures, offering high-quality imaging in compact, easily maneuverable devices.
Exploring the field of sustainable transportation, Medigus is involved in the development of electric vehicles (EVs). This initiative reflects the company's commitment to environmental sustainability and its diversification into new, high-growth areas.
Alongside EVs, Medigus is developing technologies for wireless charging of vehicle batteries. This innovation aims to enhance the convenience and efficiency of using electric vehicles, pushing forward the boundaries of what's possible in EV infrastructure technology.
